- The clinical candidate, PF-06939926, consists of a recombinant AAV Glossary Link vector expressing a miniaturized version of the DMD gene, which encodes the domains... read more
Raises Series B round co-led by Versant Ventures and Novartis Venture Fund, with Forbion, Epidarex... read more
Bellicum today announced that the U.S. Food and Drug Administration has lifted the clinical hold on studies of BPX-501 in the U.S. The decision follows consultation with the FDA and agreement on... read more
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and CEPI – the Coalition for Epidemic Preparedness Innovations – today announced a partnership under which Inovio will develop vaccine candidates... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,